Unlocking the Radiosensitizing Potential of MYC inhibition in Neuroendocrine Malignancies |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
07/15/2025 to 07/14/2027 |
$49.00 |
Gray Zone - Unmasking Collapse: Navigating Airspace Changes During Radiation |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
06/24/2025 to 06/23/2026 |
$0.00 |
Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
06/23/2025 to 06/22/2027 |
$49.00 |
Minimizing Bowel Gas Artifact in CT-guided Online Adaptive Radiotherapy with Prolonged Supine Positioning |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
06/06/2025 to 06/05/2027 |
$49.00 |
Gray Zone - Conebeam CT Scan Reveals a Space Invader: Fire All Beams or Fall Back? |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
06/06/2025 to 06/05/2026 |
$0.00 |
Moving from the Background Towards the Spotlight: A Critical Review of Radiation Therapy for Locally Advanced Pancreas Cancer |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
05/15/2025 to 05/14/2027 |
$49.00 |
Gray Zone - Which Way to (INDI)GO? |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
05/15/2025 to 05/14/2026 |
$0.00 |
Stereotactic Body Radiation Therapy for Primary Lung Cancer and Metastases: A Case Based Discussion on Challenging Cases |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
05/06/2025 to 05/05/2027 |
$49.00 |
Radiotherapy for Meningiomas – Where Do We Stand and What’s on the Horizon? |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
05/05/2025 to 05/04/2027 |
$49.00 |
Gray Zone - A Blast from the Past: Definitive Management of Favorable Early Stage Hodgkin Lymphoma Ineligible for Systemic Therapy |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
04/14/2025 to 04/13/2026 |
$0.00 |
A Randomized Study of Consolidation Chemoradiation (CTRT) versus Observation after first line chemotherapy (CT) in Advanced Gall Bladder Cancers (GBC... |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
04/14/2025 to 04/13/2027 |
$49.00 |
2025 Quarter 2 - Journal Reviewer CME |
- 3.00 AMA PRA Category 1 Credit™
|
Journal Activities |
04/01/2025 to 07/31/2025 |
$0.00 |
Appropriateness Criteria for Radiotherapy in the Setting of Presumed Early-stage Lung Cancer |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Journal Activities |
03/26/2025 to 03/25/2027 |
$49.00 |
Gray Zone - Unresectable Pancreatic Adenocarcinoma: Evidence-Based Medicine or a Gut Feeling? |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
03/13/2025 to 03/12/2026 |
$0.00 |
Gray Zone - Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine |
- 1.00 AMA PRA Category 1 Credit™
|
Journal Activities |
02/21/2025 to 02/20/2026 |
$0.00 |